Anupam Rasayan India Limited — Investor Meet, 19-08-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Anupam Rasayan delivered robust Q1 FY'26 results: consolidated revenue ₹486 Cr (+91% YoY), EBITDA ₹129 Cr (+118% YoY, 26.3% margin), and PAT ₹49 Cr (+297% YoY). Exports hit 58%. Strong growth from Pharma (24% of revenue, 3x YoY) and Performance Materials (12% of revenue, 2x YoY) segments. New agreements boosted order book to ₹14,646 Cr, including molecules for semiconductors, electronics, and EV/battery. Preferential issue funds made the company long-term net debt-free. Management is confident of 30%+ FY'26 revenue growth with working capital optimization as customer inventory normalizes.